Friday, November 5, 2004
A little Brisbane, California biotech company has landed an $878 million federal government contract to produce anthrax vaccine. The purchase is the first under a bill signed by President Bush in July. The government will buy enough vaccine for about 25 million people.
The contract is more than twice the entire market capitalization of VaxGen, Inc., a company that lost a hefty $26 million last year.